Antibiotic modified anticancer compounds for the treatment of non-genetic anti-cancer and anticancer pharmaceutical composition comprising the same

摘要

The present invention relates to an antibiotic-modified anticancer drug compound for gene non-toxic anticancer treatment and an anticancer pharmaceutical composition comprising the same, wherein the modified antibiotic anticancer drug according to the present invention has a therapeutic effect by targeting only the mitochondria of cancer cells, so that nuclear DNA Unlike conventional chemotherapy, which damages and kills cancer cells, it does not cause gene denaturation and thus can prevent cancer recurrence. In addition, the mitochondrial targeted therapy using the compound according to the present invention acquires drug resistance by general anticancer treatment, making it difficult to treat. It can effectively treat difficult malignant tumors.